The first cohort of editorial fellows joined APS in April 2024, bringing their rich array of experiences and backgrounds to ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...
Parallel Experiment gets a new trailer and a new release date. Watch the latest Parallel Experiment trailer for this upcoming ...
Women with ongoing urinary incontinence could avoid invasive bladder pressure tests, as new research shows that a range of ...